Welcome > Support > Reference Treatises  
 
 
E
 
Read
Writer Panagene     (Date : 2016-07-13 09:47:26)
Subject [Scientific publications] [2015]Low frequency of KRAS mutation in pancreatic ductal adenocarcinomas in Korean patients and its prognostic value
Content

Pancreas. 2015 Apr;44(3):484-92. doi: 10.1097/MPA.0000000000000280.

Low frequency of KRAS mutation in pancreatic ductal adenocarcinomas in Korean patients and its prognostic value.

Kwon MJ1Jeon JYPark HRNam ESCho SJShin HSKwon JHKim JSHan BKim DHChoi YL.

Author information

1From the Departments of *Pathology and †Surgery, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang; Departments of ‡Pathology and §Surgery, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul; Department of Hematological Oncology, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang; and ¶Laboratory of Cancer Genomics and Molecular Pathology, Samsung Biomedical Research Institute, Samsung Medical Center, #Department of Pathology, Samsung Medical Center, Sungkyunkwan University College of Medicine, and **Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University School of Medicine, Seoul, Korea.

Abstract

OBJECTIVES:

Low prevalence and prognostic relevance of KRAS mutations in Korean pancreatic ductal adenocarcinomas (PDACs) need to be validated with sensitive detection method.

METHODS:

Peptide nucleic acid (PNA)-mediated polymerase chain reaction (PCR) clamping was used to precisely detect KRAS mutation in 72 paraffinized tumor samples and was validated by pancreatic cell lines to compare the efficiency of direct sequencing.

RESULTS:

The PNA-mediated PCR clamping detected mutant allele proportions of as low as 0.5% against a background of wild-type DNA and was 20-fold more sensitive than direct sequencing through the validation of pancreatic cell lines. Peptide nucleic acid-mediated PCR clampingdetected KRAS mutations in 47.2% of 72 PDACs. Low tumor cellularity and low PCR amplification efficiency led to be undetected or failed by direct sequencing in pancreatic paraffinized samples.KRAS mutations were an independent worse prognostic factor predicting a reduced progression-free survival rate in the postoperative chemotherapy group.

CONCLUSIONS:

Peptide nucleic acid clamp real-time PCR was a sensitive method for detecting KRAS status in paraffinized PDAC samples. We identified a low KRAS mutation rate among the Korean PDAC patients using PNA clamp real-time PCR, potentially implicating epidemiological characteristics. The low KRAS mutation rate and its prognostic role may suggest the further survival benefit in Korean PDAC patients.


 

 No   Subject Writer File Count
   47           [Scientific publications] [2016]Comparison of EGFR .. Panagene 4159
   46           [Scientific publications] [2015]IDH Mutation Analys.. Panagene 20437
          [Scientific publications] [2015]Low frequency of KR.. Panagene 3513
   44           [Scientific publications] [2015]Simultaneous genoty.. Panagene 298
   43           [Scientific publications] [2014]Simultaneous diagno.. Panagene 278
   42           [Scientific publications] [2014]KRAS Mutation Detec.. Panagene 285
   41           [Scientific publications] [2013]Detection of EGFR m.. Panagene 332
   40           [Scientific publications] [2013]Detection and compa.. Panagene 297
   39           [Scientific publications] [2013]Detection of BRAF V.. Panagene 309
   38           [Scientific publications] [2013]Comparison of Direc.. Panagene 280
   37           [Scientific publications] [PNAClamp]Detection of EG.. Panagene 5630
   36           [Scientific publications] [Clamp]Rapid and Sensitiv.. panagene 6631
   35           [Scientific publications] [PNA microarray] Developm.. Panagene 6952
   34           [Scientific publications] [PANArray] JHDM3A module.. Panagene 1171
   33           [Scientific publications] [PNA Chip vs DNA Chip cli.. Panagene 1371
   32           [Scientific publications] [Panagene publication] PN.. Panagene 1228
   31           [Scientific publications] [Panagene publication] PN.. panagene 1239
   30           [Scientific publications] [Panagene publication] Pe.. panagene 1207
   29           [Scientific publications] [Panagene publication] Hi.. panagene 1180
   28           [Scientific publications] [PNA]Membrane-based hybri.. Panagene 1151
 

< 1 2 3 >